Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard C Nice

Showing results (51-60 of 173) with videos related to

Pageof 18
Sort By:
Molecular Omics|September 26, 2018
Tissue and plasma proteomics for early stage cancer detectionLiyuan Peng, David I Cantor, Canhua Huang, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
Antioxidant Therapy in Cancer: Rationale and ProgressMaochao Luo, Li Zhou, Zhao Huang, et al.
Signal Transduction and Targeted Therapy|October 8, 2020
Emerging role of tumor cell plasticity in modifying therapeutic responseSiyuan Qin, Jingwen Jiang, Yi Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 3, 2022
Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cellsQingxin Fan, Jing Zuo, Hailong Tian, et al.
Autophagy|September 23, 2016
Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancerKui Wang, Wei Gao, Qianhui Dou, et al.
Signal Transduction and Targeted Therapy|July 4, 2020
Overcoming cancer therapeutic bottleneck by drug repurposingZhe Zhang, Li Zhou, Na Xie, et al.
Journal of Hematology & Oncology|July 19, 2022
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and managementPing Jin, Jingwen Jiang, Li Zhou, et al.
Expert Review of Proteomics|March 10, 2017
Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identificationShuyue Fu, Xiang Liu, Maochao Luo, et al.
Expert Review of Proteomics|August 11, 2020
Recent advances in autophagic machinery: a proteomic perspectiveXingyun Wu, Li Luo, Ruxin Kong, et al.
Journal of Nanobiotechnology|December 28, 2024
Copper-coordination driven brain-targeting nanoassembly for efficient glioblastoma multiforme immunotherapy by cuproptosis-mediated tumor immune microenvironment reprogrammingYang Chen, Hailong Tian, Xiaodian Zhang, et al.
Pageof 18

Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
Molecular Omics|September 26, 2018
Tissue and plasma proteomics for early stage cancer detectionLiyuan Peng, David I Cantor, Canhua Huang, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
Antioxidant Therapy in Cancer: Rationale and ProgressMaochao Luo, Li Zhou, Zhao Huang, et al.
Signal Transduction and Targeted Therapy|October 8, 2020
Emerging role of tumor cell plasticity in modifying therapeutic responseSiyuan Qin, Jingwen Jiang, Yi Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 3, 2022
Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cellsQingxin Fan, Jing Zuo, Hailong Tian, et al.
Autophagy|September 23, 2016
Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancerKui Wang, Wei Gao, Qianhui Dou, et al.
Signal Transduction and Targeted Therapy|July 4, 2020
Overcoming cancer therapeutic bottleneck by drug repurposingZhe Zhang, Li Zhou, Na Xie, et al.
Journal of Hematology & Oncology|July 19, 2022
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and managementPing Jin, Jingwen Jiang, Li Zhou, et al.
Expert Review of Proteomics|March 10, 2017
Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identificationShuyue Fu, Xiang Liu, Maochao Luo, et al.
Expert Review of Proteomics|August 11, 2020
Recent advances in autophagic machinery: a proteomic perspectiveXingyun Wu, Li Luo, Ruxin Kong, et al.
Journal of Nanobiotechnology|December 28, 2024
Copper-coordination driven brain-targeting nanoassembly for efficient glioblastoma multiforme immunotherapy by cuproptosis-mediated tumor immune microenvironment reprogrammingYang Chen, Hailong Tian, Xiaodian Zhang, et al.
Pageof 18